Zymeworks Price to Sales Ratio 2016-2022 | ZYME

Historical PS ratio values for Zymeworks (ZYME) over the last 10 years. The current P/S ratio for Zymeworks as of February 03, 2023 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Zymeworks P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2023-02-03 9.48 16.39
2022-06-30 5.30 $0.58 9.16
2022-03-31 6.55 $0.53 12.34
2021-12-31 16.39 $0.51 32.00
2021-09-30 29.04 $0.44 65.65
2021-06-30 34.69 $0.41 84.59
2021-03-31 31.58 $0.62 51.02
2020-12-31 47.26 $0.78 60.88
2020-09-30 46.58 $0.51 90.54
2020-06-30 36.07 $0.64 56.06
2020-03-31 35.47 $0.64 55.41
2019-12-31 45.46 $0.84 53.94
2019-09-30 24.80 $1.79 13.87
2019-06-30 22.00 $1.67 13.17
2019-03-31 16.18 $2.25 7.19
2018-12-31 14.68 $1.88 7.81
2018-09-30 15.70 $3.23 4.86
2018-06-30 14.78 $3.23 4.57
2018-03-31 12.02 $2.42 4.97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.597B $0.027B
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $158.293B 9.67
GSK (GSK) United Kingdom $71.300B 9.41
Bio-Rad Laboratories (BIO.B) United States $12.069B 28.64
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.996B 0.00
Myovant Sciences (MYOV) United Kingdom $2.614B 0.00
Arcus Biosciences (RCUS) United States $1.485B 22.29
Biohaven (BHVN) United States $1.240B 0.00
Emergent Biosolutions (EBS) United States $0.697B 5.48
ADC Therapeutics SA (ADCT) Switzerland $0.356B 0.00
Enzo Biochem (ENZ) United States $0.070B 0.00
Ambrx Biopharma (AMAM) United States $0.070B 0.00
SQZ Biotechnologies (SQZ) United States $0.024B 0.00
Gelesis Holdings (GLS) United States $0.024B 0.00